Check out our most popular compounded medications! Get Started
Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used to treat conditions such as hypertension, angina pectoris, atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Indications include hypertension, angina pectoris, atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. The capsules are designed with Methocel E4M, a controlled-release polymer, which ensures a gradual and sustained release of the active ingredient, verapamil hydrochloride, over an extended period of time. This slow release mechanism allows for consistent therapeutic effects, reduced dosing frequency, and improved patient compliance, particularly beneficial for medications requiring a controlled and prolonged release profile.
Verapamil hydrochloride, the active ingredient, is a calcium channel blocker. It functions by inhibiting the influx of calcium into the cells of the heart and blood vessels. This action results in a decrease in blood pressure and heart rate, effectively alleviating the symptoms of the aforementioned cardiovascular conditions. The slow release capsules are also gluten free, making them a suitable choice for individuals with gluten sensitivities or celiac disease.
Bayview Pharmacy's Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) represent a appropriate treatment option for those managing cardiovascular conditions. We encourage anyone with questions or concerns about this formulation to reach out to us for further information and guidance.
Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) is a compounded formulation designed to provide a controlled and prolonged release of the active ingredient, Verapamil. This formulation utilizes Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, making it an ideal choice for medications requiring a controlled release profile.
Verapamil is a calcium channel blocker that is primarily used in the treatment of hypertension, angina pectoris, atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. By blocking calcium channels in the heart and blood vessels, Verapamil helps to lower blood pressure and improve blood flow. Additionally, it is used to slow the heart rate and reduce the risk of irregular heartbeats.
It is crucial to take this medication as prescribed by your healthcare provider and to regularly monitor your blood pressure and heart rate. Common side effects of Verapamil include dizziness, headache, nausea, and constipation. If you experience any unusual symptoms or if your condition worsens, it is important to contact your healthcare provider immediately.
This formulation is gluten-free, making it suitable for patients with dietary restrictions or sensitivities. As with any medication, it is important to discuss any potential allergies or interactions with your healthcare provider before starting treatment.
Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) is a potent medication primarily used in the management of various cardiovascular conditions. These include hypertension, angina pectoris, atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. The medication functions by inhibiting the action of specific chemicals in the body that stimulate the heart to beat with increased force and speed. This action aids in lowering blood pressure and enhancing the flow of blood through the heart.
Verapamil HCl is classified as a calcium channel blocker. This means it obstructs the flow of calcium into the cells of the heart and blood vessels. This blockage allows these cells to relax and widen, which in turn reduces the workload on the heart and improves blood flow. This mechanism of action is crucial in managing cardiovascular conditions and improving the overall health of the patient.
The Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) are designed to be taken orally, typically once or twice a day as prescribed by a healthcare professional. It is crucial to adhere to the prescribed dosage and not to discontinue the medication without first consulting with your doctor. This is because abrupt discontinuation can lead to adverse effects or a rebound of the condition being treated.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication or active ingredient over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications requiring a controlled and prolonged release profile.
Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) are meticulously formulated with Methocel E4M, a type of controlled-release polymer. This advanced formulation is designed to gradually release the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism reduces the need for frequent dosing and enhances patient compliance, particularly for medications that require a controlled and prolonged release profile.
These capsules may be used to treat a variety of conditions. They are often prescribed for the management of cluster headaches and migraine headaches, providing relief from these debilitating conditions. They may also be used to treat Raynaud's phenomenon, a condition that affects blood flow to the extremities and can cause discomfort and discoloration.
In addition, Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) may be used to manage certain types of abnormal heart rhythms, such as atrial flutter and atrial fibrillation. By controlling these irregular rhythms, these capsules can help to improve heart function and reduce the risk of serious complications.
Another potential use for these capsules is in the treatment of hypertrophic cardiomyopathy, a condition in which the heart muscle becomes abnormally thick. By helping to manage this condition, these capsules can improve heart function and reduce symptoms such as shortness of breath and chest pain.
Furthermore, Verapamil HCl 120 mg Slow Release Capsules (Gluten Free) may be used to treat certain types of chest pain (angina) and to control heart rate in conditions in which the heart is beating too fast or too slow. By managing these conditions, these capsules can help to improve quality of life and reduce the risk of serious complications.
If you have any questions about the use of this formulation for any of these conditions, please do not hesitate to reach out for further information.
Verapamil HCl 120 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the medication over an extended period of time, offering sustained therapeutic effects.
The slow release formulation offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to gradually release the encapsulated medication over an extended period of time.
Yes, Verapamil HCl 120 mg Slow Release Capsules are gluten-free.
The slow release mechanism works by gradually releasing the medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, in the formulation of the capsules.
Reduced dosing frequency can improve patient compliance, as it is easier for patients to remember to take their medication. It can also reduce the risk of side effects associated with high peak plasma concentrations of the medication.
"Improved patient compliance" means that patients are more likely to take their medication as prescribed. This is often achieved by reducing the frequency of dosing, making it easier for patients to remember to take their medication.
A controlled and prolonged release profile refers to the way in which a medication is gradually released into the body over an extended period of time. This is achieved through the use of controlled-release polymers, such as Methocel E4M, in the formulation of the capsules.
Patients who require a medication with a controlled and prolonged release profile can benefit from Verapamil HCl 120 mg Slow Release Capsules. This includes patients who need sustained therapeutic effects and those who would benefit from reduced dosing frequency.
As with any medication, Verapamil HCl 120 mg Slow Release Capsules can have side effects. However, the slow release formulation is designed to reduce the risk of side effects associated with high peak plasma concentrations of the medication. Always consult your healthcare provider for more information.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
